NASDAQ:AXSM | News — Page 3 | Axsome Therapeutics, Inc.

AXSM News — Page 3

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2017-11-08Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 2.02,8.01,9.01.
2017-10-20Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 1.01,9.01.
2017-09-18Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-09-11Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-08-09Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2017-07-26Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-07-18Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-07-07Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01.
2017-06-19Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 5.02,7.01,9.01.
2017-06-02Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 5.07.
2017-05-09Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 2.02,8.01,9.01.
2017-03-31Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-03-30Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-03-21Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-03-14Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-03-07Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2017-02-14Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-02-10Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-01-12Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2017-01-04Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2016-11-14Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2016-11-10Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 1.01,2.03,3.02,8.01,9.01.
2016-09-02Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 5.02,8.01,9.01.
2016-08-10Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2016-07-13Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 7.01,9.01.
2016-07-12Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 4.02.
2016-06-10Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 5.07.
2016-05-11Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 2.02,9.01.
2016-05-05Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2016-04-21Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2016-03-29Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 2.02,8.01,9.01.
2016-03-22Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 8.01,9.01.
2015-11-24Current reportSEC filingAxsome Therapeutics, Inc. filed Form 8-KAxsome Therapeutics, Inc. filed Form 8-K covering items 5.03,9.01.